Share on StockTwits

Smith & Nephew plc (NYSE:SNN)‘s stock had its “buy” rating reiterated by Jefferies Group in a research note issued on Friday.

Shares of Smith & Nephew plc (NYSE:SNN) traded down 0.49% on Friday, hitting $91.25. The stock had a trading volume of 374,544 shares. Smith & Nephew plc has a one year low of $55.22 and a one year high of $100.90. The stock has a 50-day moving average of $79.73 and a 200-day moving average of $75.04. The company has a market cap of $16.297 billion and a P/E ratio of 29.39.

Smith & Nephew plc (NYSE:SNN) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.89 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.93 by $0.04. On average, analysts predict that Smith & Nephew plc will post $4.13 earnings per share for the current fiscal year.

A number of other firms have also recently commented on SNN. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Smith & Nephew plc in a research note on Thursday. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note on Thursday. Finally, analysts at Summer Street raised their price target on shares of Smith & Nephew plc from $100.00 to $112.00 in a research note on Thursday. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $97.00.

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.